Advertisement
Screener

Allurion Technologies, Inc. (ALUR) Overview

Allurion Technologies, Inc. (ALUR) Overview

  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.46; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -1.53; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -1.28; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual -0.31; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.25$0.49$0.99$1.97$3.93$7.852025-09-292026-09-29$0.25$1.01$4.12$16.82$68.71$280.612021-09-292026-09-29$0.25$1.01$4.12$16.82$68.71$280.612021-03-292026-09-29$0.25$1.01$4.12$16.82$68.71$280.612021-03-292026-09-29$0.25$1.01$4.12$16.82$68.71$280.612021-03-292026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$1.05
Previous close
$1.11
Change
-$0.06
Change (%)
-5.06%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

ALUR
-14.63%
S&P 500
(m)

1 year

ALUR
-46.43%
S&P 500
(m)

3 years

ALUR
-99.02%
S&P 500
(m)

5 years

ALUR
-99.57%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Mar 2026 ○ Estimate (m) ● Actual -0.46

-1.61-0.310.992.283.5830 Sept 2024: estimate (m); actual 3.4030 Sept 2024(m)31 Mar 2025: estimate (m); actual -0.3131 Mar 2025(m)30 Jun 2025: estimate (m); actual -1.2830 Jun 2025(m)30 Sept 2025: estimate (m); actual -1.5330 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.4631 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202631 Mar 2026(m)-0.46(m)(m)
1 Jul 202530 Sept 2025(m)-1.53(m)(m)
1 Apr 202530 Jun 2025(m)-1.28(m)(m)
1 Jan 202531 Mar 2025(m)-0.31(m)(m)
1 Jul 202430 Sept 2024(m)3.40(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -3.81

-59.46-45.35-31.24-17.13-3.0231 Dec 2022: estimate (m); actual -37.7531 Dec 2022(m)31 Dec 2023: estimate (m); actual -59.3831 Dec 2023(m)31 Dec 2024: estimate (m); actual -3.2031 Dec 2024(m)31 Dec 2025: estimate (m); actual -3.8131 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-3.81(m)(m)
1 Jan 202431 Dec 2024(m)-3.20(m)(m)
1 Jan 202331 Dec 2023(m)-59.38(m)(m)
1 Jan 202231 Dec 2022(m)-37.75(m)(m)

Revenue vs. Earnings

USD

31 Mar 2026 ■ Revenue 2.95M ■ Earnings -6.09M — Profit margin -206.82%

-13.74M-448.1%-7.34M-354.1%-0.93M-260.1%5.47M-166.0%30 Jun 2025: revenue 3.38M; earnings -9.34M; profit margin -276.27%30 Jun 202530 Sept 2025: revenue 2.66M; earnings -11.88M; profit margin -447.10%30 Sept 202531 Dec 2025: revenue 3.61M*; earnings -6.04M*; profit margin -167.04%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 2.95M; earnings -6.09M; profit margin -206.82%31 Mar 2026

31 Dec 2025 ■ Revenue 15.23M ■ Earnings -28.75M — Profit margin -188.80%

-100.46M-189.8%-39.69M-133.7%21.08M-77.5%81.85M-21.4%31 Dec 2022: revenue 64.21M; earnings -37.74M; profit margin -58.78%31 Dec 202231 Dec 2023: revenue 53.47M; earnings -82.82M; profit margin -154.89%31 Dec 202331 Dec 2024: revenue 32.11M; earnings -7.20M; profit margin -22.42%31 Dec 202431 Dec 2025: revenue 15.23M; earnings -28.75M; profit margin -188.80%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$1.05(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$1.05High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning ALUR

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 31 Mar 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-33.35M
Profit margin
-264.74%
Return on assets · 12 month
-127.26%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
137.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.12K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
2.94%*
Total return · month
-27.59%*
Total return · quarter
-72.51%*
Total return · half year
34.62%*
Total return · year to date
-14.63%*
Total return · 1 year
-46.43%*
Total return · 3 years
-99.02%*
Total return · 5 years
-99.57%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$12.60M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Allurion Technologies, Inc. Overview

View more →

(m)

(m)

SEC CIK
1964979
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
11 HURON DR STE 200, NATICK, Massachusetts, 01760, United States
Fiscal year end
1231
Phone
508-647-4000

Similar stocks

Stock NameCountryMarket CapPE Ratio
Picard Medical, Inc. (PMI)United States$0.011B-0.01
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
CERENOME, INC. (CNSY)United States$0.014B
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
AETHLON MEDICAL INC (AEMD)United States$0.005B